Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mylan Laboratories Ltd.

Division of Mylan NV
mylanlabs.in

Latest From Mylan Laboratories Ltd.

Takeda Offloads Xiidra As Expected, For $3.4bn Upfront To Novartis

As widely anticipated, Takeda has reached an agreement to divest an ex-Shire ophthalmology drug, as it streamlines the combined post-acquisition business to focus on core therapeutic pillars.

Ophthalmic Deals

EMA’s Clinical Data Policy One Year On: 50 Products, 3,000 Documents And ‘Positive Feedback’

The European Medicines Agency has published more than 3,000 clinical documents on 50 individual medicines since its policy on the proactive publication of clinical data came into effect in October 2016. It says it has had “positive feedback” from those who have accessed data under the policy.

Clinical Trials Europe

Asia Executives To Watch: Novartis China, GSK India, Cipla

Novartis’s former head of West China is moving to lead its global cardio-metabolic franchise, while GSK India and Cipla have made key personnel appointments on the manufacturing front.

Commercial Appointments

First Sofosbuvir WHO Prequalification To Widen Access But How Far?

WHO’s prequalification of the first sofosbuvir from Gilead licensee Mylan is expected to expand access to the HCV treatment, but much will depend on donor funding priorities, say experts. Gilead hopes direct negotiations with payers in certain territories can move the access needle further.

Drug Safety Government Payers
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Matrix Laboratories Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Mylan NV
  • Senior Management
  • B. Hari Babu, PhD, CEO
  • Contact Info
  • Mylan Laboratories Ltd.
    Phone: (91) 40 30866666
    Plot No 564/A/22, Road No. 92
    Jubilee Hills
    Hyderabad , 500034
    India
Advertisement
Advertisement
UsernamePublicRestriction

Register